Overview

A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazidebased Treatment Regimen With Optional Addition of Amlodipine

Status:
Completed

Trial end date:
2006-01-01

Target enrollment:

Participant gender:

Summary

This study is designed to compare the long-term efficacy and safety of an aliskiren based regimen to an HCTZ based treatment regimen with optional addition of amlodipine in patients with essential hypertension.

Phase:

Phase 3

Details

Lead Sponsor:

Novartis

Treatments:

Amlodipine